e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice?
Catherine Hyams, O. Martin Williams, Philip Williams
Source:
ERJ Open Res, 6 (1) 00223-2019; 10.1183/23120541.00223-2019
Journal Issue:
January
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Catherine Hyams, O. Martin Williams, Philip Williams. Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice?. ERJ Open Res, 6 (1) 00223-2019; 10.1183/23120541.00223-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Usefulness of urinary pneumococcal antigen testing in patients with community acquired pneumonia
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
The diagnostic yield of the pneumococcal urinary antigen test in clinical practice and its impact on antibiotic therapy
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals
Source: ERJ Open Res, 2 (4) 00011-2016; 10.1183/23120541.00011-2016
Year: 2016
Impact of determination of urine pneumococcal antigen in the diagnosis of community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Clinical features of patients with pneumococcal urinary antigen positivity, in a cohort of hospitalised community acquired pneumonia
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Do physicians use urinary pneumococcal antigen test (UPAT) appropriately?
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003
Investigation of factors associated with result of pneumococcal urinary antigen in the microbiological investigation of pneumococcal lower respiratory infections
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
Severe community acquired pneumonia: clinical and aetiological evaluation
Source: Eur Respir J 2007; 30: Suppl. 51, 673s
Year: 2007
Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021
Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Severe community-acquired pneumonia in China: epidemiology and clinical practice
Source: International Congress 2019 – Chinese programme 2019: Part II
Year: 2019
Differentiation between pneumococcal and viral pneumonia in children: what is the best combination of nonspecific markers?
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003
Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017
Lower respiratory tract infections: diagnosis and treatment in clinical practice
Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice"
Year: 2014
Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 858-864
Year: 2011
Legionella pneumonia: clinical presentation and treatment
Source: Annual Congress 2008 - Legionella infection: from outbreak to prevention
Year: 2008
The relationship between the result of urinary antigen detection kit for
Streptococcus pneumoniae
and clinical effect of treatment in patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept